

Toan Bernard
About
Life sciences strategy consultant
Strategy consultant with 5yrs of international experience across the healthcare sector such as with pharma, CDMO/CRO services, MedTech, healthcare providers and investment groups in the EU5 and North America. Project experience covers the pharma value chain from due diligences of early-stage pipeline assets to go-to-market strategy to lifecycle management for clients ranging from local access teams to the C-suite
Social Media:
Skills
Business Portfolio Management
Due Diligence
Life Sciences
M&A Advisory Services
M&A analysis
Market Access
Market Sizing
Revenue Modeling
Open for
fulltime
Work Experience
L.E.K. Consulting
2022-08 - 2024-09
Associate Consultant
Munich
fulltime
Leading key workstreams and managing up to 2 associates in 15+ projects and 5+ proposals such as: − Developed DCF-based NPV valuations of 3 C> biotechs in a portfolio assessment case to validate the business plan of the C-suite of an EU-based VC with USD 1.5bn in assets − Built a 10yrs market sizing model and analysed a customer survey in a VDD to determine the potential market share of a chain of 350 aesthetic clinics in EU5 and support fundraising for an EU25 expansion − Developed a 10yrs patient-flow based revenue forecast in a CDD to estimate the peak revenues and support the acquisition of a rare disease drug/device combination for the V-suite of a UK mid-cap pharma − Evaluated the value proposition and hospitals’ cost benefits of using a diagnostic device in an indication expansion case to inform a go/no-go investment decision for the C-suite of a FR small-cap MedTech − Reviewed the feasibility of the business plan of a small-cap medical consumables manufacturer in a CDD to inform an investment decision for the V-suite of a CH small-cap private equity fund
IQVIA - Global Consulting
2019-06 - 2022-08
Associate
Munich
fulltime
Conducted day-to-day analyses in 20+ projects and 10+ proposals such as: − Developed a 10yrs revenue forecast in a GtM strategy case to inform the commercial capability requirements for the D-suite of a small-cap EU pharma − Benchmarked the organisational requirements and activities across business functions in a launch excellence case to optimise the launch of a dermatology product for the D-suite of a mid-cap pharma − Evaluated the value proposition and mapped the key stakeholders for a market entry case of a new insulin delivery device to identify relevant pricing pathways for the D-suite of a large-cap pharma − Characterised the patient segmentation, treatment paradigm and payer coverage in a GtM case to support the re-positioning of a metabolic drug for the D-suite of a large-cap pharma • Supported the development of a new AIML offering with stakeholders across business units and worked closely with <4 data scientists to bridge technical and scientific data, achieving > €2mn in 2yrs
Academic Experience
IE Business School and Bocconi University (exchange programme) -
2017.09 - 2019.02
Master of Science, MSc in International Management
St George's Medical School of London -
2012.09 - 2015.07
Bachelor of Science, BSc in Biomedical Sciences